Overview

Update
IPO / Stock
Went Public on Apr 12, 2006 / NASDAQ:VNDA
Headquarters:
Washington, DC
Description:
Vanda Pharmaceuticals (NASDAQ: VNDA) is a biopharmaceutical company focused on the development and commercialization of products for the
Categories:
Biopharma, Health Care, Biotechnology
Website:
http://www.vandapharma.com
Social:

Company Details

Update
Founded:
2003
Contact:
3012941900
Employees:
51 - 100 | 5 in Crunchbase

Vanda Pharmaceuticals (NASDAQ: VNDA) is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders to address unmet needs.

The company has assembled an experienced team along with a portfolio of clinical and commercial stage programs with the goal of bringing important new treatment options to patients.

Funding Rounds (1) - $54M

Update
DateAmount / RoundValuationLead InvestorInvestors
Oct, 2014$54M / Post Ipo Equity0

Current Team (5)

Update

Board Members and Advisors (2)

Update

Offices/Locations (1)

Update
  • Headquarters

    2200 Pennsylvania Ave NW

    Suite 300E

    Washington, DC 20037

    USA

Past Team (2)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos